Beijing Scitop Bio-tech Co., Ltd.
SZSE:300858.SZ
19.72 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| 93.48 | 109.891 | 109.539 | 96.577 | 93.284 | 91.919 | 71.175 | 11.535 | 35.018 |
| Depreciation & Amortization
| 20.618 | 18.046 | 16.136 | 9.845 | 5.183 | 4.6 | 4.08 | 1.28 | 0.808 |
| Deferred Income Tax
| -2.058 | -0.163 | -1.263 | 0.415 | -0.284 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| -4.348 | 1.5 | 7.788 | 0 | 0 | 0 | 0 | 44.446 | 0 |
| Change In Working Capital
| 20.529 | 29.01 | 4.95 | -35.628 | 1.082 | -8.347 | 5.57 | 0 | 0 |
| Accounts Receivables
| 39.221 | 9.271 | 19.962 | -22.791 | 8.055 | -19.479 | -18.061 | 0 | 0 |
| Inventory
| 11.711 | 1.914 | -8.113 | -14.562 | -1.697 | 1.475 | 8.553 | 0 | 0 |
| Accounts Payables
| -23.055 | 17.988 | -5.635 | 1.31 | -4.992 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -7.348 | -0.163 | -1.263 | 0.415 | -0.284 | -9.822 | -2.982 | 0 | 0 |
| Other Non Cash Items
| -11.943 | -8.491 | -20.358 | -4.122 | -1.278 | 1.377 | 3.176 | -24.529 | -33.14 |
| Operating Cash Flow
| 107.267 | 148.457 | 110.267 | 66.672 | 98.271 | 89.55 | 84.001 | 32.732 | 2.685 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -178.475 | -84.18 | -67.572 | -21.28 | -46.249 | -95.988 | -47.249 | -21.059 | -5.658 |
| Acquisitions Net
| 0.053 | 0.001 | 7.853 | 21.297 | 46.649 | 0.075 | 0 | -7.082 | -6.912 |
| Purchases Of Investments
| -2,039.763 | -2,002.996 | -1,394 | -915.67 | -200.9 | -10 | -195 | -62.5 | 0 |
| Sales Maturities Of Investments
| 1,478.475 | 1,714.137 | 1,696.707 | 532.679 | 202.194 | 10.112 | 256.736 | 2.5 | 0 |
| Other Investing Activites
| -561.235 | 0 | 9.581 | -21.28 | -46.249 | 1.008 | 3.194 | -6.534 | -5.658 |
| Investing Cash Flow
| -739.71 | -373.038 | 252.57 | -404.254 | -44.556 | -94.793 | 17.682 | -94.675 | -12.57 |
| Financing Activities: | |||||||||
| Debt Repayment
| -1.62 | -1.247 | -0.788 | 0 | -8.3 | -8.3 | -13 | -13 | -13 |
| Common Stock Issued
| 0 | 0 | 0 | -12.307 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -52.699 | -74.463 | -82.518 | 0 | -0.356 | -69.646 | -20.414 | -32.995 | -1.609 |
| Other Financing Activities
| -1.62 | 692.579 | -0.788 | 439.71 | 0.3 | 8 | 22.515 | 91.198 | 67.25 |
| Financing Cash Flow
| -54.319 | 618.116 | -83.306 | 439.71 | -8.356 | -61.646 | -10.899 | 45.204 | 52.641 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0 | -0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -683.762 | 393.535 | 279.531 | 102.128 | 45.359 | -66.888 | 90.784 | -16.739 | 42.757 |
| Cash At End Of Period
| 191.596 | 875.298 | 481.763 | 202.232 | 100.104 | 54.745 | 121.633 | 30.849 | 47.588 |